SEC Comment Letter for Biofrontera AG (CIK 0001712641) — Jan 28, 2020

Biofrontera AG (CIK 0001712641)
Date: Jan. 28, 2020 · CIK: 0001712641 · Accession: 0000000000-20-000718

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-236021

Date

January 27, 2020

Author

Not clearly detected

Form

UPLOAD

Company

Biofrontera AG (CIK 0001712641)

Letter

January 27, 2020 Thomas Schaffer Chief Financial Officer Biofrontera AG Hemmelrather Weg 201 D-51377 Leverkusen Germany Re:Biofrontera AG Registration Statement on Form F-3 Filed January 22, 2020 File No. 333-236021 Dear Mr. Schaffer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Paul Fischer at 202-551-3415 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Stephen Older, Esq.

Show Raw Text

January 27, 2020
Thomas Schaffer
Chief Financial Officer
Biofrontera AG
Hemmelrather Weg 201
D-51377 Leverkusen
Germany
Re:Biofrontera AG
Registration Statement on Form F-3
Filed January 22, 2020
File No. 333-236021
Dear Mr. Schaffer:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Paul Fischer at 202-551-3415 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Stephen Older, Esq.

SecProbe.io